Form 4: Rhythm Pharmaceuticals Corporate Controller Reports Stock Sale to Cover Taxes
SEC Form 4 Filing
Christopher Paul German, Corporate Controller & CAO of Rhythm Pharmaceuticals, sold 368 shares of common stock on April 2, 2024, to cover withholding taxes related to vested restricted stock units.
Summary
- On March 20, 2024, Christopher Paul German, Corporate Controller & CAO of Rhythm Pharmaceuticals, acquired 1,163 shares of common stock upon the vesting of restricted stock units.
- On April 2, 2024, German sold 368 shares of Rhythm Pharmaceuticals' common stock at a price of $41.76 per share.
- The sale was executed to cover withholding taxes associated with the vesting of restricted stock units, pursuant to a pre-arranged non-Rule 10b5-1 trading plan.
- Following the reported transactions, German directly owns 795 shares of Rhythm Pharmaceuticals' common stock and 3,487 restricted stock units.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the filing relates to routine stock transactions by an insider to cover tax obligations. It doesn't indicate any fundamental change in the company's prospects.
Industry Context
Form 4 filings are a routine part of insider trading activity and are used to disclose transactions by company insiders. The sale of shares to cover taxes is a common practice.
Key Dates
| Date | Description |
|---|---|
| 03/20/2024 | Restricted stock units vested, resulting in the acquisition of 1,163 shares. |
| 04/02/2024 | Sale of 368 shares of common stock at $41.76 per share. |
| 04/03/2024 | Date of Power of Attorney execution. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.